Stephen J. Denelsky's most recent trade in Harvard Bioscience Inc. was a trade of 110,000 Common Stock done . Disclosure was reported to the exchange on Sept. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Harvard Bioscience Inc | Stephen J. Denelsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2025 | 110,000 | 110,000 (0%) | 0% | 0 | Common Stock |